Tarsus Pharmaceuticals Inc (TARS) Straddle

Trading a TARS straddle lets you take a pure volatility position on Tarsus Pharmaceuticals Inc without committing to a direction. Tarsus Pharmaceuticals Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate TARS straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on TARS profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Tarsus Pharmaceuticals Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the TARS straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases.

Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the TARS straddle is the cleanest expression of that view. Our scanner prices every TARS straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a TARS straddle into a catalyst or short a TARS straddle to harvest decay, the options straddle setups that matter are all in one place.